RxDoctor Payments Data

Joseph Zarge, MD

Vascular Surgery · Atlanta, GANPI 1528006525

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Artivion, Inc. at 49.1% of the total. Reporting peaked in 2024 at $2,678 and has fallen 93.3% since, to $179 in 2025. That places this record below the midpoint for vascular surgery clinicians in GA, where the typical reported total is $5,638.

$5,091in general payments, 2019–2025

Across 15 payments — averaging $339.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Artivion, Inc.$3K
  • W. L. Gore & Associates, Inc.$1K
  • KCI USA, Inc.$850
  • Silk Road Medical, Inc.$336
  • Shockwave Medical, Inc$125
  • Boston Scientific$23
  • plus $5 from 1 others
$4,080in research payments, 2019–2025

Across 3 payments — averaging $1360.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Silk Road Medical, Inc.$4K

What the payments were for

  • Consulting fees$85017%
  • Speaking & faculty fees$2,50049%
  • Food & beverage$1,74134%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,091 in reported general payments places this provider in the 45th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia →

Medicare billing

Part B allowed, 2024
$283,815
Medicare patients
1,277
Services billed
2,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban104$75,753
XareltoRivaroxaban54$47,030
ClopidogrelClopidogrel Bisulfate216$2,072
Cilostazol109$1,920
Gabapentin44$571
Atorvastatin Calcium37$277
Rosuvastatin Calcium15$237
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$203
Oxycodone Hcl13$137
Tramadol Hcl19$32

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →